Cancer: Rising Incidence Among Younger Adults. Cancer rates among adolescents and adults under 50 are rising globally, but ...
Health on MSN
6 Common Foods That Make You Gassy and Bloated
Foods such as beans, dairy, cruciferous vegetables, and fruits are healthy additions to your diet, but they can also leave ...
UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...
Researchers don’t know what might account for the link between ultraprocessed foods and colorectal cancer risk. But they do ...
Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...
Worldwide, colorectal cancer is the second leading cause of cancer-related mortality and the third most common cancer, with incidence rates increasing among individuals younger than 50 years.1 ...
News-Medical.Net on MSN
AI analysis of biopsy slides predicts rectal cancer treatment response
Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...
A new study found that women who eat a lot of ultra-processed foods were 1.5 times more likely to develop pre-cancerous polyps before the age of 50, compared to those with healthier diets.
News-Medical.Net on MSN
Study finds low uptake of colorectal cancer testing among adults aged 45 to 49
UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...
Artios Pharma, which looking for newer targets that, like PARP inhibitors, affect the way tumors fix themselves, said its ...
Scientists are turning venom, radioisotopes, engineered proteins, and AI into powerful new tools against cancer. From ...
Funding advances Phase 2 expansion cohorts in pancreatic and colorectal cancer in ATM-negative patients for Artios’ potential first-in-class ATR Inhibitor, alnodesertib Following encouraging ESMO data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results